GAPDHP64

Across TCGA pan-cancer cohorts, GAPDHP64 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated GAPDHP64 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher GAPDHP64 RNA is associated with better overall survival. In most high-consensus cancer types, elevated GAPDHP64 expression acts as an unfavorable survival marker, although some lineages such as LUSC and THYM show a favorable association.

LUSC, KICH, and MESO are the cancer types where GAPDHP64 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.827	0.695	<.001	60	view →
KICH	OS	Median	II,III,IV	0.793	1.000	.001	52	view →
MESO	OS	Quartile	All	0.210	0.412	.002	37	view →
LUAD	OS	Tertile	All	0.692	0.865	<.001	34	view →
BLCA	DFS	Tertile	IV	0.200	0.531	<.001	26	view →
COAD	DFS	Tertile	IV	0.322	0.559	.005	26	view →
SARC	DFS	Tertile	All	0.376	0.659	<.001	23	view →
THCA	DFS	Median	IV	0.563	1.000	.006	12	view →
STAD	DFS	Median	II,III,IV	0.399	0.649	.039	6	view →
THYM	OS	Median	All	1.000	0.945	.020	4	view →
HNSC	DFS	Quartile	All	0.541	0.795	.019	4	view →
ESCA	OS	Median	All	1.000	0.574	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

GAPDHP64–LUSC (OS)

Open the LUSC breakdown →